Skip to content

Cognitive Intervention With Go and Chess in Early and Subjective Cognitive Decline

Cognitive Intervention With Go and Chess in Early and Subjective Cognitive Decline

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06281652
Acronym
Cognichess
Enrollment
80
Registered
2024-02-28
Start date
2024-02-13
Completion date
2025-02-13
Last updated
2026-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment, Subjective Cognitive Decline

Keywords

Subjective Cognitive Decline, Mild Cognitive Impairment, Cognitive enhancement, Board games

Brief summary

The goal of this clinical trial\]is to evaluate if learning to play traditional board games could improve cognition in subjects with mild cognitive impairment and subjective cognitive decline. The main questions it aims to answer are: * Do Go and Chess improve cognition? * Is a game better than the other? Is the effect of both games on cognition synergistic? * Do Go and Chess improve quality of life? * Do Go and Chess improve mood? * Do Go and Chess improve lifestyle? Participants will be randomized to one of four groups: * Group intervention with Go, once a week, for 12 weeks * Group intervention with Chess, once a week, for 12 weeks * Group intervention with Go and Chess, twice a week, for 12 weeks * Control group

Interventions

OTHERGo classes

Classes of board games (Go), performed in groups of 6-10 subjects, once a week

OTHERChess classes

Classes of board games (Chess), performed in groups of 6-10 subjects, once a week

Sponsors

University of Milano Bicocca
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of mild cognitive impairment or subjective cognitive decline * Willingness to participate in the board games classes * Living within 20-minute driving distance from the center * Signed informed consent

Exclusion criteria

* Prior knowledge of the the game rules (in case the subject knows one of the two, they can be randomized to the other one) * Significant linguistic or sensory impairment (according to clinical judgment) * Significant behavioral or psychiatric disturbances (according to clinical judgment) * Significant medical comorbidities (according to clinical judgment)

Design outcomes

Primary

MeasureTime frameDescription
General cognition12 weeksDifferences in Montreal Cognitive Assessment between groups \[continuous scale, 0-30, higher scores indicate better performances\]

Secondary

MeasureTime frameDescription
Digit Span Forward12 weeksDifferences in Digit Span Forward between groups \[continuous scale, 0-9, higher scores indicate better performances\]
Digit Span Backwards12 weeksDifferences in Digit Span Backwards between groups \[continuous scale, 0-9, higher scores indicate better performances\]
Trail Making Test - part A12 weeksDifferences in Trail Making Test - part A between groups \[time to complete the task, min 0 seconds, max N/A, higher scores indicate worse performances\]
Trail Making Test - part B12 weeksDifferences in Trail Making Test - part B between groups \[time to complete the task, min 0 seconds, max N/A, higher scores indicate worse performances\]
Semantic fluency12 weeksDifferences in Semantic fluency between groups \[continuous scale, min 0, max N/A, higher scores indicate better performances\]
Quality of life indicator12 weeksDifferences in WHO Quality of life (WHO-QoL) scale between groups \[continuous scale, min 0 max 100, higher scores indicate better quality of life\]
Depression12 weeksDifferences in geriatric depression scale scale between groups \[continuous scale, min 0 max 15, higher scores indicate worse depression\]
Lifestyle12 weeksDifferences in simple lifestyle indicator questionnaire scale between groups \[continuous scale, min 0 max 10, higher scores indicate healthier lifestyle\]

Countries

Italy

Contacts

PRINCIPAL_INVESTIGATORLucio Tremolizzo, MD, PhD

Fondazione IRCCS San Gerardo

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026